These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 9347318)
1. Antagonistic effects of isofloxythepin on dopamine D1 and D2 receptors and behaviors in rats. Lau YS; Fung YK; Anderson TM Gen Pharmacol; 1997 Nov; 29(5):729-36. PubMed ID: 9347318 [TBL] [Abstract][Full Text] [Related]
2. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ. Crawford CA; Rowlett JK; McDougall SA; Bardo MT Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063 [TBL] [Abstract][Full Text] [Related]
3. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin. Lau YS; Runice C Eur J Pharmacol; 1985 Oct; 116(1-2):25-31. PubMed ID: 2865162 [TBL] [Abstract][Full Text] [Related]
4. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT; White FJ Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [TBL] [Abstract][Full Text] [Related]
5. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related]
6. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat. Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase. Deveney AM; Waddington JL Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354 [TBL] [Abstract][Full Text] [Related]
8. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
9. D-cycloserine decreases both D1 and D2 dopamine receptors number and their function in rat brain. Gandolfi O; Rimondini R; Dall'Olio R Pharmacol Biochem Behav; 1994 Jun; 48(2):351-6. PubMed ID: 7916464 [TBL] [Abstract][Full Text] [Related]
10. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors. Zackheim JA; Abercrombie ED Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986 [TBL] [Abstract][Full Text] [Related]
11. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction. Kozell LB; Machida CA; Neve RL; Neve KA J Biol Chem; 1994 Dec; 269(48):30299-306. PubMed ID: 7982941 [TBL] [Abstract][Full Text] [Related]
12. Importance of D1 and D2 receptors in the dorsal caudate-putamen for the locomotor activity and stereotyped behaviors of preweanling rats. Charntikov S; Der-Ghazarian T; Herbert MS; Horn LR; Widarma CB; Gutierrez A; Varela FA; McDougall SA Neuroscience; 2011 Jun; 183():121-33. PubMed ID: 21443930 [TBL] [Abstract][Full Text] [Related]
13. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals? Cools AR; Lubbers L; van Oosten RV; Andringa G Neuropharmacology; 2002 Feb; 42(2):237-45. PubMed ID: 11804620 [TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents. Protais P; Chagraoui A; Arbaoui J; Mocaër E Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199 [TBL] [Abstract][Full Text] [Related]
15. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C. Deveney AM; Waddington JL Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598 [TBL] [Abstract][Full Text] [Related]
18. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum. Hu XT; Brooderson RJ; White FJ Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592 [TBL] [Abstract][Full Text] [Related]
19. Dopamine D1 and D2 receptors and their signal system present in coated vesicles prepared from bovine striatal tissue. Ozaki N; Moroi K; Kadota T; Suzuki S; Kadota K J Neurochem; 1994 Feb; 62(2):582-91. PubMed ID: 8294921 [TBL] [Abstract][Full Text] [Related]
20. Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences. Harsing LG; Zigmond MJ Neuroscience; 1997 Mar; 77(2):419-29. PubMed ID: 9472401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]